Symbols / ICLR Stock $103.21 +1.02% ICON Public Limited Company

Healthcare • Diagnostics & Research • Ireland • NMS
ICLR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Mr. Barry Balfe
Exch · Country NMS · Ireland
Market Cap 8.03B
Enterprise Value 10.98B
Income 599.48M
Sales 8.10B
FCF (ttm) 925.35M
Book/sh 122.25
Cash/sh 6.14
Employees 39,800
Insider 10d —
IPO May 15, 1998
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 13.91
Forward P/E 8.44
PEG 16.92
P/S 0.99
P/B 0.84
P/C —
EV/EBITDA 7.22
EV/Sales 1.36
Quick Ratio 1.01
Current Ratio 1.06
Debt/Eq 38.26
LT Debt/Eq —
EPS (ttm) 7.42
EPS next Y 12.23
EPS Growth -98.70%
Revenue Growth 0.60%
EPS Gr Q/Q -98.80%
Rev Gr Q/Q —
Earnings (next) 2026-04-28
Earnings (prior) 2025-10-22
ROA 4.20%
ROE 6.27%
ROIC —
Gross Margin 28.16%
Oper. Margin 12.67%
Profit Margin 7.40%
Shs Outstand 76.36M
Shs Float 75.95M
Insider Own 0.67%
Instit Own 107.56%
Short Float 4.08%
Short Ratio 3.50
Short Interest 3.09M
52W High 211.00
vs 52W High -51.09%
52W Low 66.57
vs 52W Low 55.04%
Beta 1.28
Impl. Vol. 0.78%
Rel Volume 1.69
Avg Volume 1.92M
Volume 3.24M
Target (mean) $132.08
Tgt Median $130.00
Tgt Low $75.00
Tgt High $180.00
# Analysts 13
Recom Buy
Prev Close $102.17
Price $103.21
Change 1.02%
About

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$132.08
Mean price target
2. Current target
$103.21
Latest analyst target
3. DCF / Fair value
$218.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$103.21
Low
$75.00
High
$180.00
Mean
$132.08

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-26 up BMO Capital Market Perform → Outperform $130
2026-03-11 main Citigroup Neutral → Neutral $120
2026-03-09 main Barclays Equal-Weight → Equal-Weight $120
2026-02-23 up Jefferies Hold → Buy $135
2026-02-18 up TD Cowen Hold → Buy $120
2026-01-22 main TD Cowen Hold → Hold $183
2026-01-08 down Truist Securities Buy → Hold $222
2025-12-15 main Barclays Equal-Weight → Equal-Weight $200
2025-11-13 init BMO Capital — → Market Perform $175
2025-10-24 main TD Cowen Hold → Hold $172
2025-10-24 main Barclays Equal-Weight → Equal-Weight $185
2025-10-02 main Barclays Equal-Weight → Equal-Weight $190
2025-09-09 down Jefferies Buy → Hold $175
2025-09-03 up Rothschild & Co Neutral → Buy $236
2025-09-02 main Baird Outperform → Outperform $224
2025-08-21 down Citigroup Buy → Neutral $200
2025-07-25 main Mizuho Outperform → Outperform $225
2025-07-25 main UBS Buy → Buy $240
2025-07-25 main Truist Securities Buy → Buy $234
2025-07-25 main Barclays Equal-Weight → Equal-Weight $180
News
RSS: Latest ICLR news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
8,281.68
+1.99%
8,120.18
+4.89%
7,741.39
+41.24%
5,480.83
Operating Revenue
8,281.68
+1.99%
8,120.18
+4.89%
7,741.39
+41.24%
5,480.83
Cost Of Revenue
5,845.32
+2.19%
5,719.95
+3.49%
5,527.05
+39.13%
3,972.61
Reconciled Cost Of Revenue
5,845.32
+2.19%
5,719.95
+3.49%
5,527.05
+39.13%
3,972.61
Gross Profit
2,436.36
+1.51%
2,400.23
+8.39%
2,214.34
+46.82%
1,508.21
Operating Expense
1,216.85
-10.16%
1,354.51
+0.46%
1,348.27
+49.75%
900.32
Selling General And Administration
728.35
-5.23%
768.56
-1.31%
778.75
+33.05%
585.33
Total Expenses
7,062.17
-0.17%
7,074.46
+2.90%
6,875.31
+41.09%
4,872.93
Operating Income
1,219.51
+16.62%
1,045.72
+20.74%
866.08
+42.47%
607.90
Total Operating Income As Reported
1,097.81
+14.82%
956.15
+20.23%
795.24
+110.09%
378.53
EBITDA
1,563.88
+2.79%
1,521.44
+12.99%
1,346.55
+122.40%
605.48
Normalized EBITDA
1,685.58
+4.63%
1,611.00
+13.66%
1,417.39
+55.72%
910.24
Reconciled Depreciation
488.50
-16.63%
585.95
+2.89%
569.51
+80.81%
314.99
EBIT
1,075.38
+14.95%
935.49
+20.39%
777.04
+167.49%
290.49
Total Unusual Items
-121.70
-35.87%
-89.57
-26.44%
-70.84
+76.76%
-304.76
Total Unusual Items Excluding Goodwill
-121.70
-35.87%
-89.57
-26.44%
-70.84
+76.76%
-304.76
Special Income Charges
-121.70
-35.87%
-89.57
-26.44%
-70.84
+76.76%
-304.76
Restructuring And Mergern Acquisition
121.70
+35.87%
89.57
+26.44%
70.84
-76.76%
304.76
Net Income
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Pretax Income
869.18
+39.19%
624.47
+9.97%
567.85
+188.72%
196.68
Net Non Operating Interest Income Expense
-228.63
+31.07%
-331.69
-45.87%
-227.39
-113.59%
-106.46
Interest Expense Non Operating
206.20
-33.70%
311.02
+48.68%
209.19
+122.99%
93.81
Net Interest Income
-228.63
+31.07%
-331.69
-45.87%
-227.39
-113.59%
-106.46
Interest Expense
206.20
-33.70%
311.02
+48.68%
209.19
+122.99%
93.81
Interest Income Non Operating
8.61
+71.70%
5.01
+113.82%
2.35
+308.54%
0.57
Interest Income
8.61
+71.70%
5.01
+113.82%
2.35
+308.54%
0.57
Other Income Expense
-121.70
-35.87%
-89.57
-26.44%
-70.84
+76.76%
-304.76
Tax Provision
77.71
+561.42%
11.75
-80.22%
59.41
+43.73%
41.33
Tax Rate For Calcs
0.00
+368.42%
0.00
-81.84%
0.00
-50.22%
0.00
Tax Effect Of Unusual Items
-10.83
-536.46%
-1.70
+77.04%
-7.41
+88.43%
-64.05
Net Income Including Noncontrolling Interests
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Net Income From Continuing Operation Net Minority Interest
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Net Income From Continuing And Discontinued Operation
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Net Income Continuous Operations
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Minority Interests
—
—
0.00
0.00
Normalized Income
902.34
+28.87%
700.20
+23.12%
568.73
+44.39%
393.90
Net Income Common Stockholders
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Diluted EPS
9.53
+28.78%
7.40
+20.72%
6.13
+172.44%
2.25
Basic EPS
9.60
+28.69%
7.46
+20.13%
6.21
+172.37%
2.28
Basic Average Shares
82.48
+0.46%
82.10
+0.70%
81.53
+21.49%
67.11
Diluted Average Shares
83.03
+0.38%
82.72
+0.22%
82.54
+21.26%
68.07
Diluted NI Availto Com Stockholders
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Depreciation Amortization Depletion Income Statement
488.50
-16.63%
585.95
+2.89%
569.51
+80.81%
314.99
Depreciation And Amortization In Income Statement
488.50
-16.63%
585.95
+2.89%
569.51
+80.81%
314.99
Earnings From Equity Interest Net Of Tax
0.00
+100.00%
-0.38
+87.79%
-3.14
-45.12%
-2.16
Total Other Finance Cost
31.04
+20.87%
25.68
+25.01%
20.54
+55.35%
13.22
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
16,877.68
-0.66%
16,989.86
-1.14%
17,185.28
-1.16%
17,387.09
Current Assets
3,530.49
+3.49%
3,411.47
+5.65%
3,229.07
+9.79%
2,941.20
Cash Cash Equivalents And Short Term Investments
538.78
+41.76%
380.06
+30.84%
290.48
-61.47%
753.92
Cash And Cash Equivalents
538.78
+42.50%
378.10
+30.94%
288.77
-61.61%
752.21
Other Short Term Investments
0.00
-100.00%
1.95
+14.07%
1.71
+0.06%
1.71
Receivables
2,851.27
-1.66%
2,899.31
+3.49%
2,801.49
+35.15%
2,072.95
Accounts Receivable
1,401.99
-21.69%
1,790.32
+3.40%
1,731.39
+28.94%
1,342.77
Gross Accounts Receivable
1,437.65
-21.09%
1,821.86
+3.99%
1,751.95
+29.79%
1,349.85
Allowance For Doubtful Accounts Receivable
-35.66
-13.10%
-31.53
-53.36%
-20.56
-190.38%
-7.08
Other Receivables
1,365.76
+34.20%
1,017.73
-0.35%
1,021.31
+50.22%
679.88
Taxes Receivable
83.52
-8.47%
91.25
+87.03%
48.79
-3.00%
50.30
Prepaid Assets
—
—
—
114.32
Other Current Assets
140.44
+6.31%
132.10
-3.64%
137.09
+19.92%
114.32
Total Non Current Assets
13,347.18
-1.70%
13,578.39
-2.71%
13,956.21
-3.39%
14,445.89
Net PPE
530.48
+5.78%
501.52
-0.52%
504.15
-5.69%
534.57
Gross PPE
1,076.50
+16.83%
921.40
+1.89%
904.33
-9.30%
997.09
Accumulated Depreciation
-546.01
-30.04%
-419.88
-4.93%
-400.17
+13.48%
-462.52
Properties
0.00
0.00
0.00
0.00
Land And Improvements
3.72
+0.00%
3.72
+0.00%
3.72
+0.00%
3.72
Buildings And Improvements
66.13
-5.62%
70.07
-1.14%
70.88
-13.58%
82.02
Machinery Furniture Equipment
741.89
+24.47%
596.05
+8.22%
550.78
-10.28%
613.89
Other Properties
202.71
+3.14%
196.55
-8.06%
213.78
-5.96%
227.33
Leases
62.03
+12.79%
55.00
-15.60%
65.17
-7.07%
70.12
Goodwill And Other Intangible Assets
12,611.20
-2.07%
12,877.94
-2.81%
13,250.33
-3.63%
13,748.77
Goodwill
9,051.41
+0.33%
9,022.08
+0.56%
8,971.67
-0.73%
9,037.93
Other Intangible Assets
3,559.79
-7.68%
3,855.86
-9.88%
4,278.66
-9.17%
4,710.84
Investments And Advances
57.95
+23.81%
46.80
+43.43%
32.63
+30.71%
24.96
Long Term Equity Investment
57.95
+23.81%
46.80
+43.43%
32.63
+30.71%
24.96
Non Current Accounts Receivable
72.80
-7.23%
78.47
-14.86%
92.17
+3.34%
89.19
Non Current Deferred Assets
74.76
+1.49%
73.66
-4.25%
76.93
+58.97%
48.39
Non Current Deferred Taxes Assets
74.76
+1.49%
73.66
-4.25%
76.93
+58.97%
48.39
Other Non Current Assets
—
—
—
70.56
Total Liabilities Net Minority Interest
7,354.68
-5.09%
7,749.12
-10.80%
8,687.32
-6.79%
9,320.26
Current Liabilities
2,796.41
-1.03%
2,825.61
+5.02%
2,690.60
+8.54%
2,478.94
Payables And Accrued Expenses
759.84
+24.68%
609.43
-6.70%
653.18
+7.08%
610.01
Payables
759.84
+24.68%
609.43
-6.70%
653.18
+128.06%
286.41
Accounts Payable
704.59
+18.32%
595.47
-2.61%
611.40
+169.36%
226.98
Current Accrued Expenses
—
—
406.30
+25.56%
323.60
Employee Benefits
—
14.74
+13.08%
13.03
-19.86%
16.26
Pensionand Other Post Retirement Benefit Plans Current
225.82
-41.42%
385.50
-2.62%
395.86
-4.19%
413.19
Total Tax Payable
55.26
+295.60%
13.97
-66.57%
41.78
-29.70%
59.43
Income Tax Payable
55.26
+295.60%
13.97
-66.57%
41.78
-29.70%
59.43
Current Debt And Capital Lease Obligation
66.55
-54.60%
146.56
+48.33%
98.81
-5.99%
105.10
Current Debt
29.76
-72.98%
110.15
+99.73%
55.15
+0.00%
55.15
Other Current Borrowings
29.76
-72.98%
110.15
+99.73%
55.15
+0.00%
55.15
Current Capital Lease Obligation
36.78
+1.01%
36.41
-16.59%
43.66
-12.60%
49.95
Current Deferred Liabilities
1,614.80
-2.40%
1,654.55
+9.76%
1,507.49
+13.86%
1,324.01
Current Deferred Revenue
1,614.80
-2.40%
1,654.55
+9.76%
1,507.49
+13.86%
1,324.01
Other Current Liabilities
129.40
+337.73%
29.56
-16.16%
35.26
+32.38%
26.64
Total Non Current Liabilities Net Minority Interest
4,558.27
-7.42%
4,923.51
-17.90%
5,996.71
-12.35%
6,841.33
Long Term Debt And Capital Lease Obligation
3,536.48
-6.73%
3,791.76
-19.85%
4,730.68
-14.62%
5,540.65
Long Term Debt
3,396.40
-7.34%
3,665.44
-20.30%
4,599.04
-14.53%
5,381.16
Long Term Capital Lease Obligation
140.09
+10.90%
126.32
-4.04%
131.64
-17.46%
159.48
Non Current Pension And Other Postretirement Benefit Plans
—
14.74
+13.08%
13.03
-19.86%
16.26
Tradeand Other Payables Non Current
125.83
-32.58%
186.65
-21.96%
239.19
+38.97%
172.11
Non Current Deferred Liabilities
812.49
-9.63%
899.10
-9.05%
988.59
-8.97%
1,085.98
Non Current Deferred Revenue
—
—
—
0.73
Non Current Deferred Taxes Liabilities
812.49
-9.63%
899.10
-9.05%
988.59
-8.97%
1,085.98
Other Non Current Liabilities
83.47
+81.46%
46.00
+82.34%
25.23
-4.20%
26.33
Stockholders Equity
9,523.00
+3.05%
9,240.74
+8.74%
8,497.96
+5.34%
8,066.83
Common Stock Equity
9,523.00
+3.05%
9,240.74
+8.74%
8,497.96
+5.34%
8,066.83
Capital Stock
6.59
-1.69%
6.70
+0.75%
6.65
+0.14%
6.64
Common Stock
6.59
-1.69%
6.70
+0.75%
6.65
+0.14%
6.64
Share Issued
80.76
-2.11%
82.50
+0.94%
81.72
+0.21%
81.55
Ordinary Shares Number
80.76
-2.11%
82.50
+0.94%
81.72
+0.21%
81.55
Additional Paid In Capital
7,020.23
+1.12%
6,942.67
+1.50%
6,840.31
+1.58%
6,733.91
Retained Earnings
2,724.81
+11.96%
2,433.72
+33.62%
1,821.38
+28.62%
1,416.08
Gains Losses Not Affecting Retained Earnings
-229.93
-60.22%
-143.51
+16.34%
-171.54
-88.63%
-90.94
Other Equity Adjustments
-229.93
-60.22%
-143.51
+16.34%
-171.54
-88.63%
-90.94
Total Equity Gross Minority Interest
9,523.00
+3.05%
9,240.74
+8.74%
8,497.96
+5.34%
8,066.83
Total Capitalization
12,919.40
+0.10%
12,906.18
-1.46%
13,097.00
-2.61%
13,447.99
Working Capital
734.09
+25.30%
585.86
+8.80%
538.47
+16.49%
462.26
Invested Capital
12,949.16
-0.52%
13,016.33
-1.03%
13,152.15
-2.60%
13,503.14
Total Debt
3,603.03
-8.51%
3,938.32
-18.45%
4,829.49
-14.46%
5,645.74
Net Debt
2,887.38
-15.01%
3,397.49
-22.17%
4,365.42
-6.80%
4,684.10
Capital Lease Obligations
176.87
+8.68%
162.74
-7.17%
175.30
-16.30%
209.43
Net Tangible Assets
-3,088.20
+15.09%
-3,637.20
+23.47%
-4,752.37
+16.36%
-5,681.95
Tangible Book Value
-3,088.20
+15.09%
-3,637.20
+23.47%
-4,752.37
+16.36%
-5,681.95
Available For Sale Securities
—
46.80
+43.43%
32.63
+44.44%
22.59
Investmentin Financial Assets
—
46.80
+43.43%
32.63
+44.44%
22.59
Other Equity Interest
1.30
+12.22%
1.16
+0.00%
1.16
+2.47%
1.13
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
1,286.65
+10.82%
1,161.03
+106.11%
563.32
-32.06%
829.14
Cash Flow From Continuing Operating Activities
1,286.65
+10.82%
1,161.03
+106.11%
563.32
-32.06%
829.14
Net Income From Continuing Operations
791.47
+29.26%
612.34
+21.18%
505.30
+229.87%
153.19
Depreciation Amortization Depletion
488.50
-16.63%
585.95
+2.89%
569.51
+80.81%
314.99
Depreciation
—
—
106.43
+40.99%
75.48
Amortization Cash Flow
—
—
463.09
+93.35%
239.50
Depreciation And Amortization
488.50
-16.63%
585.95
+2.89%
569.51
+80.81%
314.99
Amortization Of Intangibles
—
—
463.09
+93.35%
239.50
Other Non Cash Items
95.22
+25.09%
76.12
+2.47%
74.29
-39.19%
122.17
Stock Based Compensation
45.87
-17.60%
55.67
-21.07%
70.52
-47.31%
133.84
Asset Impairment Charge
15.73
+81.11%
8.69
-69.81%
28.77
+43.57%
20.04
Deferred Tax
-100.54
-17.73%
-85.40
+31.67%
-124.98
-106.19%
-60.62
Deferred Income Tax
-100.54
-17.73%
-85.40
+31.67%
-124.98
-106.19%
-60.62
Operating Gains Losses
6.91
-65.60%
20.09
+303.47%
-9.87
-193.66%
10.54
Gain Loss On Investment Securities
—
2.41
—
0.89
Net Foreign Currency Exchange Gain Loss
6.91
-64.93%
19.71
+251.48%
-13.01
-114.88%
-6.05
Change In Working Capital
-56.51
+49.73%
-112.42
+79.57%
-550.22
-507.59%
135.00
Change In Receivables
9.39
+111.95%
-78.58
+89.57%
-753.29
-885.84%
95.86
Changes In Account Receivables
349.31
+519.36%
-83.30
+80.20%
-420.69
-470.61%
113.51
Change In Other Working Capital
-37.74
-128.05%
134.57
-30.26%
192.94
+379.14%
-69.12
Change In Other Current Assets
-28.16
+83.28%
-168.40
-1763.90%
10.12
-90.65%
108.26
Investing Cash Flow
-266.79
-17.71%
-226.65
-55.38%
-145.87
+97.58%
-6,024.23
Cash Flow From Continuing Investing Activities
-266.79
-17.71%
-226.65
-55.38%
-145.87
+97.58%
-6,024.23
Net PPE Purchase And Sale
-168.06
-19.45%
-140.69
+1.03%
-142.16
-51.64%
-93.75
Purchase Of PPE
-168.06
-19.45%
-140.69
+1.03%
-142.16
-51.64%
-93.75
Capital Expenditure
-168.06
-19.45%
-140.69
+1.03%
-142.16
-51.64%
-93.75
Net Investment Purchase And Sale
-14.57
-2.65%
-14.20
-282.92%
-3.71
-4.13%
-3.56
Purchase Of Investment
-17.26
-21.60%
-14.20
-152.90%
-5.61
-23.17%
-4.56
Sale Of Investment
2.69
0.00
-100.00%
1.91
+91.17%
1.00
Net Business Purchase And Sale
-84.16
-17.27%
-71.77
0.00
+100.00%
-5,916.93
Purchase Of Business
-84.16
-17.27%
-71.77
0.00
+100.00%
-5,916.93
Net Other Investing Changes
—
—
—
-10.00
Financing Cash Flow
-837.18
+0.81%
-844.04
+2.33%
-864.17
-116.90%
5,114.73
Cash Flow From Continuing Financing Activities
-837.18
+0.81%
-844.04
+2.33%
-864.17
-116.90%
5,114.73
Net Issuance Payments Of Debt
-360.28
+59.74%
-895.00
-11.88%
-800.00
-115.91%
5,027.32
Issuance Of Debt
2,317.48
+526.35%
370.00
+393.33%
75.00
-98.73%
5,905.10
Repayment Of Debt
-2,677.76
-111.68%
-1,265.00
-44.57%
-875.00
+0.32%
-877.78
Long Term Debt Issuance
2,317.48
+526.35%
370.00
+393.33%
75.00
-98.73%
5,905.10
Long Term Debt Payments
-2,677.76
-111.68%
-1,265.00
-44.57%
-875.00
+0.32%
-877.78
Net Long Term Debt Issuance
-360.28
+59.74%
-895.00
-11.88%
-800.00
-115.91%
5,027.32
Short Term Debt Issuance
—
—
—
5,905.10
Short Term Debt Payments
—
—
—
-877.78
Net Short Term Debt Issuance
—
—
—
5,027.32
Net Common Stock Issuance
-500.00
0.00
+100.00%
-99.98
0.00
Common Stock Payments
-500.00
0.00
+100.00%
-99.98
0.00
Repurchase Of Capital Stock
-500.00
0.00
+100.00%
-99.98
0.00
Proceeds From Stock Option Exercised
36.19
-29.01%
50.97
+42.21%
35.84
-69.77%
118.59
Net Other Financing Charges
-13.09
-81706.25%
-0.02
+52.94%
-0.03
+99.89%
-31.18
Changes In Cash
182.68
+102.23%
90.33
+120.22%
-446.73
-455.87%
-80.36
Effect Of Exchange Rate Changes
-22.00
-2106.22%
-1.00
+94.04%
-16.72
-116.38%
-7.73
Beginning Cash Position
378.10
+30.94%
288.77
-61.61%
752.21
-10.48%
840.30
End Cash Position
538.78
+42.50%
378.10
+30.94%
288.77
-61.61%
752.21
Free Cash Flow
1,118.59
+9.63%
1,020.34
+142.27%
421.15
-42.73%
735.39
Interest Paid Supplemental Data
—
317.98
+50.76%
210.92
+98.60%
106.20
Income Tax Paid Supplemental Data
—
163.78
+40.80%
116.32
+111.09%
55.10
Earnings Losses From Equity Investments
0.00
-100.00%
0.38
-87.79%
3.14
+45.12%
2.16
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category